Findings to date from the ASCUS-LSIL Triage Study (ALTS)

Archives of Pathology and Laboratory Medicine

Volumn 127, Issue 8, 2003, Pages 946-949

  Schiffman, Mark ^a   Solomon, Diane ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

AGE; CLINICAL TRIAL; COLPOSCOPY; CONDYLOMA; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DNA DETERMINATION; FEMALE; HISTOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PATIENT REFERRAL; PREDICTION; PREVALENCE; RANDOMIZATION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; EMERGENCY HEALTH SERVICE; ENDOMETRIAL STROMAL TUMOR; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW; UNITED STATES; UTERINE CERVIX TUMOR; VIROLOGY;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; ENDOMETRIAL STROMAL TUMORS; FEMALE; HUMANS; RANDOMIZED CONTROLLED TRIALS; TRIAGE; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 0042173242     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Manos MM, Kinney WK, Hurley LB, et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA. 1999;281:1605-1610.
2. Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer. 2002;97:72-81.
3. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin. 2002;52:23-47.
4. Davey DD, Woodhouse S, Styer P, Stastny J, Mody D. Atypical epithelial cells and specimen adequacy: current laboratory practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med. 2000;124:203-211.
5. The 1991 Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda Workshop. JAMA. 1992;267:1892.
6. Castle PE, Lorincz AT, Mielzynska-Lohna I, et al. Results of human papillomavirus DNA testing with the Hybrid Capture 2 assay are reproducible. J Clin Microbiol. 2002;40:1088-1090.
7. Smith A, Sherman ME, Scott DR, et al. Review of the Bethesda System Atlas does not improve reproducibility or accuracy in the classification of atypical squamous cells of undetermined significance. Cancer Cytopathol. 2000;90:201-206.
8. Schiffman M, Adrianza E, for the ALTS Group. The ASCUS-LSIL Triage Study (ALTS): design, methods, and characteristics of trial participants. Acta Cytol. 2000; 44:726-742.
9. The ALTS Group. HPV testing as a triage strategy for women with cytologic evidence of low grade squamous intraepithelial lesions: early results from a randomized trial on the clinical management of ASCUS and LSIL cytologic abnormalities. J Natl Cancer Inst. 2000;92:397-402.
10. Solomon D, Schiffman M, Tarone R, for the ALTS Group. Comparison of three management, strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001;93:293-299.
11. Solomon D, Schiffman M, Tarone R, for the ALTS Group. ASCUS LSIL Triage Study (ALTS) conclusions reaffirmed: response to a November 2001 commentary. Obstet Gynecol. 2002;99:671-674.
12. Kim JJ, Wright TC, Goldie SJ, Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA. 2002;287: 2382-2390.
13. Sherman ME, Cox JT, Schiffman M, and the ALTS Study Group. Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst. 2002;94: 102-107.
14. Ferris DG, Schiffman M, Litaker MS, for the ALTS Group. Cervicography for triage of women with mildly abnormal cervical cytology results. Am J Obstet Gynecol. 2001;185:939-943.
15. Stoler MH, Schiffman M, for the ALTS Group. Interobserver reproducibility of cervical cytologic and histologic diagnoses: realistic estimates from the ASCUS-LSIL Triage Study (ALTS). JAMA. 2001;285:1500-1505.
16. Scott DR, Hagmar B, Maddox P, et al. Comparison of equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom: implications for international comparisons of HPV testing. Cancer Cytopathol. 2002;96:14-20.
17. Sherman ME, Solomon D, Schiffman M, and the ALTS Study Group. Comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study. Am J Clin Pathol. 2001;116:386-394.
18. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-2119.
19. Wright TC, Cox JT, Massad LS, Twiggs LB, Wikinson EJ, for the 2001 ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287: 2120-2129.
20. ALTS Group. Results of a randomized trial on the management of cytologic interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gyoecol. In press.
21. ALTS Group. A randomized trial on the management of LSIL cytologic interpretations. Am J Obstet Gynecol. In press.
22. Cox JT, Schiffman M, Solomon D, for the ALTS Group. Prospective follow-up suggests similar risk of subsequent CIN 2 or 3 among women with CIN 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol. In press.
23. Guido R, Schiffman M, Solomon D, Burke L, for the ALTS Group. Postcolposcopy management strategies for patients referred with LSIL or HPV DNA positive ASCUS: a two-year prospective study. Am J Obstet Gynecol. In press.